tony w
The Clinical Journal of Pain
The Clinical Journal of Pain
Journal of Pain and Symptom Management
Bacteria that live in the gut interact with dietary components to affect health and wellness.
(Reuters) – Drug developer Zafgen Inc said on Thursday that its drug to treat obesity in diabetic patients met the main goal of reducing body weight. Patients given 1.8 mg and 1.2 mg doses of the drug, beloranib, experienced 12.7 and 13.5 percent reduction in body weight, respectively. The results were from trials conducted before the U.S. Food and Drug Administration asked Zafgen to halt all tests on the drug in December after a second patient died from an artery blockage in the lung during a trial.
Clinical Drug Investigation
The Journal of Headache and Pain
Anesthesiology
European Journal of Physical and Rehabilitation Medicine
Journal of Anesthesia